Searched for
ANTICONVULSANT DRUG
Alembic Pharmaceuticals gets USFDA nod for generic Carbamazepine tabletsAlembic Pharmaceuticals has received final approval from the USFDA for its generic Carbamazepine extended-release tablets (100 mg, 200 mg, ...28 Jul, 2025, 01.16 PM IST- Alembic Pharma gets USFDA nod for generic drugAlembic Pharmaceuticals has received the United States Food and Drug Administration approval. The approval allows them to market Carbamazep...17 Apr, 2025, 01.30 PM IST
- Zydus Lifesciences Q1 Results: Profit more than doubles on US sales growthIts U.S formulations business saw a revenue growth of 57.4% to 24.54 billion rupees, while India formulations grew by 9.1% to 12.27 billion...11 Aug, 2023, 01.47 PM IST
- Sanofi reinvigorates India business, with eye on higher growthThe company has outlined an ‘India for India’ strategy, where it will focus on diabetes, consumer health, a combination of product innovati...25 May, 2023, 03.09 PM IST
- On a path to recovery: 4 small pharma stocks with an upside potential of up to 27%As the markets get jittery, select pharma stocks are back in focus. This tends to happen in volatile markets. Some of them are small and mi...14 May, 2023, 12.28 PM IST
- Stocks in the news: Tata Motors, P&GHH, Adani Enterprises, NDTV and NPTCA wholly owned subsidiary of Gautam Adani's flagship firm, Adani Enterprises, said it will buy a majority stake in New Delhi Television, a ...24 Aug, 2022, 07.07 AM IST
- Asahi Songwon Colors zooms 4% after buying 78% stake in Atlas Life SciencesAsahi Songwon’s share price climbed to a high of Rs 346.45 as against Rs 332.70 at previous close on the BSE. The stock succumbed to profit...19 Apr, 2022, 11.27 AM IST
- Market movers: Adani Group stocks get 2 billion reasons to rally furtherAdani Group said Abu Dhabi’s International Holding Company PJSC (IHC) will invest $2 billion as primary capital in three portfolio companie...08 Apr, 2022, 07.46 PM IST
- Drug shortages persist in Russia after start of Ukraine warExperts and health authorities in Russia say the drug shortages are temporary - due to panic- buying and logistical difficulties for suppli...03 Apr, 2022, 02.17 PM IST
- Zydus gets final US FDA nod to market generic version of Vigabatrin tabletsCadila Healthcare Ltd on Thursday said group firm Zydus has received final approval from the US health regulator to market its generic vers...20 Jan, 2022, 11.50 AM IST
- Aurobindo, Actavis recall Gabapentin capsulesThe drug is manufactured by Aurobindo Pharma at its Mahabub Nagar facility in Andhra Pradesh.20 Jan, 2015, 08.17 PM IST
- Glenmark recalls three drugs from US marketGlenmark Generics is recalling multiple lots of three of its drugs from the US market due to "odd smell", according to US FDA.23 May, 2013, 05.41 PM IST
- US FDA approves Sun's new drug to market Topamax, topiramateSun Pharma today said the US Food and Drug Administration (FDA) has granted an approval for its abbreviated new drug application to market ...29 Mar, 2009, 10.00 AM IST
- Ranbaxy gets Australia nod for antipsychotic drugRanbaxy Laboratories has received the Australian drug regulator’s nod to sell its generic version of drugmaker Janssen-Cilag’s anti-schizop...25 Mar, 2009, 04.04 PM IST
- Ranbaxy gets approval to market anti-fungal drugs in AustraliaDrug major Ranbaxy Laboratories said it has received approval from Australian health regulator to market its anti-fungal tablets Serbifin T...06 Mar, 2009, 06.02 PM IST
- Orchid Chemicals gets USFDA approval for divalproex tabletsOrchid Chemicals & Pharmaceuticals has received US Food and Drug Administration approval for its abbreviated new drug application for dival...04 Dec, 2008, 12.13 PM IST
- Cadila bags USFDA nod for 3 productsPharmaceutical firm, Cadila Healthcare today said USFDA has given its nod it for the company's three products, taking the group's total num...19 Mar, 2007, 03.20 PM IST
Load More
